#United States #Philadelphia #Berger Montague #MRX #Marex Group

Class Action Against Marex Group plc: A Closer Look

Berger Montague PC, a prominent national plaintiffs' law firm, has made headlines by filing a class action lawsuit targeting Marex Group plc (NASDAQ: MRX), a London-based financial services provider. This legal action is on behalf of investors who purchased Marex shares between May 16, 2024, and August 5, 2025. The firm has urged those affected by the alleged misconduct to consider becoming lead plaintiffs in the case before the December 8, 2025, deadline.

The Nature of the Allegations

The lawsuit emerges in the wake of a startling report released by NINGI Research on August 5, 2025. Allegations were put forth claiming that Marex engaged in a protracted accounting scandal that involved a series of opaque off-balance-sheet entities. The firm is accused of executing fictitious intercompany transactions and misleading disclosures that aimed to hide substantial financial losses while artificially inflating profits and masking the true extent of risk exposure.

Key Findings from the Report

Among the most alarming revelations detailed in the report are substantial discrepancies in Marex's financial data. The allegations point to multi-million-dollar discrepancies in intercompany receivables and loans spread across Marex's extensive network, which includes over 56 individual entities. Some of the highlighted discrepancies include:
1. Fabricated Receivables: A $17 million receivable that never existed.
2. Inflated Profits: A subsidiary reportedly had profits inflated by 150% before liquidation.
3. Dramatic Asset Valuation Drops: An asset valued at $14.9 million was sold weeks later for a mere $2.5 million, with no financial loss reported.
4. Concealed Derivatives Exposure: Nearly $1 billion in off-balance-sheet derivatives reportedly hidden through a fund controlled by Marex in Luxembourg. This was allegedly utilized to create non-cash trading profits and artificially boost operating cash flow by misclassifying structured note issuance as income.

Investor Impact and Stock Price Reactions

The gravity of these allegations had an immediate impact on Marex's stock performance. Following the report's release, Marex's share price plummeted by $2.33, marking a 6.2% decrease and closing at $35.31 on a day characterized by unusually heavy trading volume. This drop is significant as it underscores the potential financial ramifications for investors who were misled by the company's purported fraudulent practices.

How Investors Can Participate

Investors who purchased Marex's securities during the indicated class period are encouraged to examine their rights and consider participating in the lawsuit. If you believe the recent developments have affected your investments, you can reach out to Berger Montague for assistance in understanding your options. The firm has provided direct contact avenues, urging investors to get in touch with Senior Counsel Andrew Abramowitz or Director of Portfolio Monitoring Services Caitlin Adorni for further guidance.

About Berger Montague

Founded in 1970, Berger Montague has carved a niche as a leader in securities class action litigation. With offices in various cities including Philadelphia, Minneapolis, and San Francisco, the firm has a rich history of representing both individual and institutional investors. The firm’s longstanding commitment to advocate for the rights of investors is reflected in its response to the Marex situation.

Marex Group's operations involve providing essential trading, clearing, and risk management solutions globally. Investors must remain vigilant, as the outcomes of such scandals can have far-reaching consequences in stock market valuations and investor confidence.

For additional information or to discuss your rights further, contact Berger Montague directly.

• ---